Updates in the Treatment of EGFR-Mutant NSCLC: Highlights from WCLC and ESMO 2023 : Episode 1

Biomarker Testing and Advancements in EGFR-Mutant NSCLC Treatment Strategies

November 13, 2023

News

Video

Insights into diagnosing EGFR-mutant lung cancer and explores evolving first-line treatment strategies, incorporating recent developments, combinations, and clinical trial data, while addressing challenges in testing and patient management.

Now Viewing

EP: 1.Biomarker Testing and Advancements in EGFR-Mutant NSCLC Treatment Strategies

EP: 2.Revolutionizing First-Line Strategies in EGFR-Mutant NSCLC: Combination Therapies

EP: 3.Impact of Combination Therapies and CNS Efficacy in EGFR-Mutant NSCLC Treatment

EP: 4.EGFR-Mutant NSCLC: Second-Line Treatment Options and Safety Data

EP: 5.Advancements in EGFR-Mutant NSCLC: ADCs and Other Targeted Therapies

EP: 6.EGFR Exon 20 Insertion NSCLC: A Comprehensive Overview

EP: 7.Unmet Needs in EGFR Exon 20 Insertion Non–Small Cell Lung Cancer

EP: 8.“Exciting Year” for Targeted Therapy Options for Mutated NSCLC, Experts Say

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!